1 paper
Hongye Zeng, Shreeram Athreya, Dingyuan Dai +4
Active surveillance (AS) is the preferred strategy for favorable-risk prostate cancer, yet current protocols rely on scheduled repeat biopsies, most of which reveal no progression…